Host-directed therapy
Showing 1 - 25 of >10,000
Tuberculosis Trial in Singapore (Doxycycline, Placebo)
Not yet recruiting
- Tuberculosis
- Doxycycline
- Placebo
-
Singapore, SingaporeNational University Hospital
Jul 21, 2022
Tuberculosis, Pulmonary Trial in Groningen (Azithromycin 250 mg)
Recruiting
- Tuberculosis, Pulmonary
- Azithromycin 250 mg
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 7, 2022
Surgery Trial (Goal-directed therapy)
Not yet recruiting
- Surgery
- Goal-directed therapy
- (no location specified)
Jul 19, 2023
Fluid Loss, Enhanced Recovery Trial in New Delhi (Goal directed Fluid Therapy, Conventional Fluid Therapy)
Recruiting
- Fluid Loss
- Enhanced Recovery
- Goal directed Fluid Therapy
- Conventional Fluid Therapy
-
New Delhi, Please Select, IndiaAnita Kulkarni
Sep 6, 2023
Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)
Not yet recruiting
- Steroid-refractory Acute Graft-versus-host Disease
- MC0518
- BAT
- (no location specified)
Oct 4, 2023
Anesthesia, ERAS, Fluid Overload Trial (Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index, standard
Not yet recruiting
- Anesthesia
- +3 more
- Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index
- standard fluid management
- (no location specified)
Nov 10, 2023
Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary
Recruiting
- Breast Cancer
- +2 more
- Systemic therapy for 12 weeks after primary registration
- +3 more
-
Tokyo, JapanTokyo Medical and Dental Univetsity
Nov 15, 2023
Kidney Injury, Acute Trial in Ghent (Early goal directed therapy during 6 hours after occurence of the early phase of acute
Withdrawn
- Kidney Injury, Acute
- Early goal directed therapy during 6 hours after occurence of the early phase of acute kidney injury
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 15, 2022
Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)
Recruiting
- Breast Cancer
- +2 more
- Stereotactic Ablative Radiation Therapy
- +2 more
-
Cairo, EgyptNational Cancer Institute
Nov 20, 2023
Renal Injury, Acute Kidney Injury Trial (Goal Directed Fluid Therapy)
Not yet recruiting
- Renal Injury
- Acute Kidney Injury
- Goal Directed Fluid Therapy
- (no location specified)
Oct 25, 2023
Hypotension During Surgery Trial (Plasma-lyte, Norepinephrine)
Not yet recruiting
- Hypotension During Surgery
- (no location specified)
Oct 10, 2023
Pulmonary Embolism Trial in New York (Anticoagulant Therapy, Catheter-Directed Therapy)
Not yet recruiting
- Pulmonary Embolism
- Anticoagulant Therapy
- Catheter-Directed Therapy
-
New York, New YorkNYU Langone Health - Tisch Hospital
Oct 18, 2022
(GDMT) Optimization and Adherence Longitudinal Study for Heart
Not yet recruiting
- Heart Failure
-
Durham, North Carolina
- +3 more
Jun 7, 2023
Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)
Not yet recruiting
- Prostate Cancer
- +2 more
- Androgen deprivation therapy (ADT)
- +3 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023
Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)
Not yet recruiting
- Advanced Non Small Cell Lung Cancer
- (no location specified)
Oct 24, 2023
Chronic GVHD Trial in United States (Ofatumumab)
Completed
- Chronic Graft Versus Host Disease
-
Phoenix, Arizona
- +3 more
Sep 30, 2022
A Virtual Heart Failure Optimization Program for Guideline
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Virtual Heart Failure Optimization Program
-
Cambridge, Ontario, CanadaCambridge Cardiac Rehab
Jan 15, 2023
Goal Directed and Liberal Fluid Therapy
Completed
- Fluid Therapy
- ICON
-
Mansoura, Eldakahlia, EgyptMansoura Oncology Center
Aug 2, 2022
Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022
Not yet recruiting
- Cancer
- Relapsed/Refractory Large B-cell Lymphoma (LBCL)
- Fludarabine (30 mg/m^2)
- +2 more
- (no location specified)
Jul 25, 2023
Pulmonary Embolism Subacute Massive Trial (Mechanical embolectomy: by hydromechanical defragmentation by pigtail, Suction
Not yet recruiting
- Pulmonary Embolism Subacute Massive
- Mechanical embolectomy: by hydromechanical defragmentation by pigtail
- Suction embolectomy by the Penumbra Indigo aspiration system
- (no location specified)
Nov 9, 2022
Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)
Completed
- Steroid Refractory GVHD
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 15, 2022
Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2023
High-risk Thoracic Cancer Surgery Trial in France (individualized goal-directed fluid therapy by Starling device, group managed
Not yet recruiting
- High-risk Thoracic Cancer Surgery
- individualized goal-directed fluid therapy by Starling device
- group managed by standard of care
-
Bron, France
- +10 more
Dec 1, 2023
NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen
Not yet recruiting
- NK-T-Cell Lymphoma, Extranodal
- 4 cycles of ESA regimen with sandwiched radiotherapy
- +2 more
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 29, 2023